SBC Medical Group Holdings Incorporated (SBC) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for SBC is $9.00, representing a +106.4% upside from the current price of $4.36. Price targets range from a low of $9.00 to a high of $9.00.
